JP2015523364A5 - - Google Patents

Download PDF

Info

Publication number
JP2015523364A5
JP2015523364A5 JP2015520652A JP2015520652A JP2015523364A5 JP 2015523364 A5 JP2015523364 A5 JP 2015523364A5 JP 2015520652 A JP2015520652 A JP 2015520652A JP 2015520652 A JP2015520652 A JP 2015520652A JP 2015523364 A5 JP2015523364 A5 JP 2015523364A5
Authority
JP
Japan
Prior art keywords
thiosulfate
agent
oxoprotective
sepsis
related condition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015520652A
Other languages
English (en)
Japanese (ja)
Other versions
JP6509112B2 (ja
JP2015523364A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/049087 external-priority patent/WO2014008273A2/en
Publication of JP2015523364A publication Critical patent/JP2015523364A/ja
Publication of JP2015523364A5 publication Critical patent/JP2015523364A5/ja
Application granted granted Critical
Publication of JP6509112B2 publication Critical patent/JP6509112B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015520652A 2012-07-03 2013-07-02 オキソ関連状態の治療、診断および/またはその進行のモニタリングのための方法 Expired - Fee Related JP6509112B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261667719P 2012-07-03 2012-07-03
US61/667,719 2012-07-03
US201261691787P 2012-08-21 2012-08-21
US61/691,787 2012-08-21
US201361748698P 2013-01-03 2013-01-03
US61/748,698 2013-01-03
PCT/US2013/049087 WO2014008273A2 (en) 2012-07-03 2013-07-02 Methods for treating, diagnosing and/or monitoring progression of oxo associated states

Publications (3)

Publication Number Publication Date
JP2015523364A JP2015523364A (ja) 2015-08-13
JP2015523364A5 true JP2015523364A5 (https=) 2016-08-25
JP6509112B2 JP6509112B2 (ja) 2019-05-08

Family

ID=49882592

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015520652A Expired - Fee Related JP6509112B2 (ja) 2012-07-03 2013-07-02 オキソ関連状態の治療、診断および/またはその進行のモニタリングのための方法

Country Status (7)

Country Link
US (1) US20150174160A1 (https=)
EP (1) EP2866565A4 (https=)
JP (1) JP6509112B2 (https=)
CN (1) CN104582490A (https=)
AU (2) AU2013286876B2 (https=)
CA (1) CA2915793A1 (https=)
WO (1) WO2014008273A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2021522519A (ja) * 2018-04-19 2021-08-30 スティッキーセル ピーティーワイ リミテッドStickycell Pty Ltd 感染症の技術分野における白血球補充
US11406607B2 (en) 2018-05-24 2022-08-09 University Of Florida Research Foundation, Inc. Compositions, methods of treatment, and containers including compositions
EP4561551A1 (en) * 2022-07-27 2025-06-04 Redox Bioscience LLC Methods and compounds for treating ulcerative colitis, systemic lupus erythematosus, sepsis, and post-sepsis syndrome
US20260086093A1 (en) 2022-09-14 2026-03-26 BiognoSYS AG Methods to determine drug target residence time and to select best drug-target candidates

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9309387D0 (en) * 1993-05-06 1993-06-16 Wellcome Found Nitric oxide scavengers
AU682894B2 (en) * 1993-10-28 1997-10-23 Institut National De La Recherche Agronomique Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man
US5990153A (en) * 1997-05-05 1999-11-23 Wood; John G. Ultrasonicated α-lipoic acid solutions for attenuating microvascular injury
US6712802B1 (en) * 1997-11-04 2004-03-30 Charles B. Cairns Metabolic therapy directed at electron transport
CN100432049C (zh) * 1998-03-09 2008-11-12 武田药品工业株式会社 环烯衍生物、其制造方法和用途
US20030190368A1 (en) * 1998-03-11 2003-10-09 Roland Stoughton Methods of diagnosis and triage using cell activation measures
FR2791571B1 (fr) * 1999-04-02 2002-10-04 Sod Conseils Rech Applic Association inhibiteur(s) de no synthase et antioxydant(s) metabolique(s)
CN1561218A (zh) * 2001-07-27 2005-01-05 努特里奇亚有限公司 用于预防和/或治疗败血症的肠道组合物
EP1302115A1 (fr) * 2001-10-16 2003-04-16 Societe Des Produits Nestle S.A. Utilisation de cystathionine
DE10151764A1 (de) * 2001-10-19 2003-05-08 Basf Ag Kombination von Liponsäure und Glutamin in Lebens- und Arzneimitteln
CN1675154A (zh) * 2002-06-07 2005-09-28 科蒂科股份有限公司 抑制巨噬细胞移动抑制因子(mif)的细胞因子或生物活性的萘衍生物
US20030235571A1 (en) * 2002-06-19 2003-12-25 Gabriel Gojon-Romanillos Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
US20100112088A1 (en) * 2003-08-29 2010-05-06 Jay Pravda Materials and methods for treatment of disorders associated with oxidative stress
US8476233B2 (en) * 2003-08-29 2013-07-02 Therapeutic Research, Llc Methods for treatment for ulcerative colitis in mammals
CA2548313A1 (en) * 2003-12-23 2005-07-14 Musc Foundation For Research Development Methods and compositions for the prevention and treatment of inflammatory diseases or conditions
FR2894482A1 (fr) * 2005-12-14 2007-06-15 Galderma Sa Utilisation d'une composition comprenant une association d'hydroquinone,d'acetonide de fluocinolone et de tretinoine, dans le traitement d'l'hyperpigmentation de la peau suite au psoriasis ou a l'eczema
US9383348B2 (en) * 2008-06-21 2016-07-05 John E. Repine Compositions and methods for treating lung disorders
KR20120110138A (ko) * 2009-12-28 2012-10-09 엔.브이. 페리콘 엘엘씨 국소용 아실 글루타치온 제제

Similar Documents

Publication Publication Date Title
Bevc et al. Measurement of breath ammonia for detection of patients with chronic kidney disease
JP2015523364A5 (https=)
Ren et al. Dynamic change of hydrogen sulfide during global cerebral ischemia–reperfusion and its effect in rats
Torraco et al. Effects of levosimendan on mitochondrial function in patients with septic shock: a randomized trial
Gu et al. Contribution of hydrogen sulfide and nitric oxide to exercise-induced attenuation of aortic remodeling and improvement of endothelial function in spontaneously hypertensive rats
BR112019004075A2 (pt) métodos para diagnosticar um indivíduo com suspeita de endometriose, para detectar mirna, para diagnosticar um indivíduo que apresenta sintomas de endometriose ou com suspeita de endometriose, para tratar um indivíduo com endometriose, para diagnosticar e tratar um indivíduo com suspeita de endometriose, para diagnosticar endometriose em um indivíduo, para diagnosticar ou prover um prognóstico para endometriose em um indivíduo e para monitorar uma resposta a um tratamento de endometriose em um indivíduo, e, kit.
MX2009013683A (es) Materiales y metodos para el tratamiento y diagnostico de trastornos asociados con estres oxidativo.
EP1940231A4 (en) Detection of lysophosphatidylcholine for prognosis or diagnosis of a systemic inflammatory condition
ATE537450T1 (de) Igfbp2-biomarker
EA200801899A1 (ru) Способ повышения устойчивости растений к пониженным температурам и/или заморозкам
EP2201370A4 (en) COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE-2 DIABETES
EA201290629A1 (ru) Способы и композиции для диагностики и прогнозирования повреждений почек и почечной недостаточности
JP2016118568A5 (https=)
WO2014186313A8 (en) Substituted bridged urea analogs as sirtuin modulators
BR112019001144A2 (pt) método e kit para determinar concentração de oxidanteem soluções desinfetantes
FR2959414B1 (fr) Combinaison de molecules aux fins de traitement d'hypotension survenant au cours du choc septique, cardiogenique, ou anaphylactique refractaire, ou hemorragique terminal, apres correction de la volemie et de l'etat de mal asthmatique refractaire
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
WO2016163727A3 (ko) 황화수소 검출용 방사성 프로브
BR112012027527A2 (pt) partículas de agente de branqueamento compreendendo percarbonato de sódio e um ativador de branqueamento
Śledziński et al. Serum cystatin C in relation to fat mass loss after bariatric surgery
TW200744701A (en) Test agent for diagnosing dyspepsia
JP2012524884A5 (https=)
Golanski et al. Revival of PFA-100–how far is it useful for the monitoring of ADP receptor antagonists?
RU2011144028A (ru) Эффекты пероральной композиции против потери костной массы и потери прикрепления
JP2018033393A5 (https=)